Literature DB >> 25937523

Roles of human UDP-glucuronosyltransferases in clearance and homeostasis of endogenous substrates, and functional implications.

Karl Walter Bock1.   

Abstract

Human UDP-glucuronosyltransferases (UGTs) are major phase II enzymes in the drug metabolism system. Despite major advances in characterization of UGT gene family members, their role in clearance and homeostasis of endogenous substrates is insufficiently understood. Endobiotic substrates including bilirubin, serotonin, eicosanoids, steroid hormones, bile acids, thyroxine and fat-soluble vitamins A and D are discussed. Species- and tissue/cell-dependent regulation of UGT expression by ligand-activated transcription factors is often involved in endobiotic homeostasis. However, roles of particular UGTs are often difficult to delineate since they function together with other enzymes and transporters. Better knowledge of endobiotic UGT substrates and consequences of their conjugation may help to understand evolutionary conserved UGT functions.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  20-HETE; 20-HETE (PubChem CID: 5283157); Bilirubin; Bilirubin (PubChem CID: 5280352); LTB4 (PubChem CID: 5280492); Serotonin; Serotonin (PubChem CID: 5202); UDP-glucuronosyltransferase; Vitamin A (PubChem CID: 445354); Vitamin D3 (PubChem CID: 5280795); Vitamins A and D

Mesh:

Substances:

Year:  2015        PMID: 25937523     DOI: 10.1016/j.bcp.2015.04.020

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  6 in total

1.  Catechol-O-Methyltransferase and UDP-Glucuronosyltransferases in the Metabolism of Baicalein in Different Species.

Authors:  Ruiya Zhang; Yonglei Cui; Yan Wang; Xiangge Tian; Lu Zheng; HaiJian Cong; Bin Wu; Xiaokui Huo; Chao Wang; BaoJing Zhang; Xiaobo Wang; Zhonghui Yu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-12       Impact factor: 2.441

Review 2.  The Ontogeny of UDP-glucuronosyltransferase Enzymes, Recommendations for Future Profiling Studies and Application Through Physiologically Based Pharmacokinetic Modelling.

Authors:  Justine Badée; Stephen Fowler; Saskia N de Wildt; Abby C Collier; Stephan Schmidt; Neil Parrott
Journal:  Clin Pharmacokinet       Date:  2019-02       Impact factor: 6.447

3.  A Gilbert syndrome-associated haplotype protects against fatty liver disease in humanized transgenic mice.

Authors:  Steffen Landerer; Sandra Kalthoff; Stefan Paulusch; Christian P Strassburg
Journal:  Sci Rep       Date:  2020-05-26       Impact factor: 4.379

4.  SOX1 promotes differentiation of nasopharyngeal carcinoma cells by activating retinoid metabolic pathway.

Authors:  Xin-Xing Lei; Yun Liu; Jin-Xing Wang; Qian Cai; Min Yan; Hui-Ping He; Quentin Liu; Zi-Jie Long; Zhong Guan
Journal:  Cell Death Dis       Date:  2020-05-07       Impact factor: 8.469

Review 5.  Beneficial Pharmacokinetic Drug Interactions: A Tool to Improve the Bioavailability of Poorly Permeable Drugs.

Authors:  Werner Gerber; Johan D Steyn; Awie F Kotzé; Josias H Hamman
Journal:  Pharmaceutics       Date:  2018-07-26       Impact factor: 6.321

Review 6.  Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression.

Authors:  Eric P Allain; Michèle Rouleau; Eric Lévesque; Chantal Guillemette
Journal:  Br J Cancer       Date:  2020-02-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.